Citigroup’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $110M | Buy |
2,582,561
+1,005,921
| +64% | +$54.6M | 0.04% | 441 |
|
|
2026
Q1 | $98.9M | Buy |
1,576,640
+220,141
| +16% | +$17.6M | 0.04% | 409 |
|
|
2025
Q4 | $129M | Sell |
1,356,499
-749,602
| -36% | -$73.5M | 0.06% | 294 |
|
|
2025
Q3 | $206M | Sell |
2,106,101
-1,926,956
| -48% | -$200M | 0.09% | 215 |
|
|
2025
Q2 | $433M | Buy |
4,033,057
+1,145,088
| +40% | +$116M | 0.21% | 82 |
|
|
2025
Q1 | $291M | Sell |
2,887,969
-249,976
| -8% | -$25.2M | 0.15% | 124 |
|
|
2024
Q4 | $280M | Buy |
3,137,945
+1,240,772
| +65% | +$109M | 0.17% | 110 |
|
|
2024
Q3 | $159M | Sell |
1,897,173
-372,163
| -16% | -$29.3M | 0.09% | 192 |
|
|
2024
Q2 | $175M | Buy |
2,269,336
+266,235
| +13% | +$19.5M | 0.11% | 166 |
|
|
2024
Q1 | $137M | Sell |
2,003,101
-677,757
| -25% | -$43.6M | 0.09% | 210 |
|
|
2023
Q4 | $155M | Buy |
2,680,858
+366,004
| +16% | +$19.5M | 0.11% | 163 |
|
|
2023
Q3 | $122M | Buy |
2,314,854
+56,509
| +3% | +$2.96M | 0.09% | 183 |
|
|
2023
Q2 | $122M | Sell |
2,258,345
-31,659
| -1% | -$1.65M | 0.08% | 189 |
|
|
2023
Q1 | $115M | Sell |
2,290,004
-38,819
| -2% | -$1.83M | 0.08% | 197 |
|
|
2022
Q4 | $108M | Sell |
2,328,823
-334,299
| -13% | -$14.5M | 0.09% | 209 |
|
|
2022
Q3 | $103M | Buy |
2,663,122
+579,828
| +28% | +$23.3M | 0.07% | 213 |
|
|
2022
Q2 | $77.6M | Buy |
2,083,294
+6,546
| +0.3% | +$266K | 0.06% | 270 |
|
|
2022
Q1 | $92M | Buy |
2,076,748
+80,752
| +4% | +$3.5M | 0.06% | 300 |
|
|
2021
Q4 | $84.8M | Sell |
1,995,996
-5,029,701
| -72% | -$211M | 0.05% | 364 |
|
|
2021
Q3 | $305M | Buy |
7,025,697
+4,384,714
| +166% | +$194M | 0.18% | 91 |
|
|
2021
Q2 | $113M | Buy |
2,640,983
+891,705
| +51% | +$37.5M | 0.07% | 270 |
|
|
2021
Q1 | $67.6M | Buy |
1,749,278
+597,049
| +52% | +$22.6M | 0.04% | 379 |
|
|
2020
Q4 | $41.4M | Sell |
1,152,229
-50,534
| -4% | -$1.82M | 0.02% | 627 |
|
|
2020
Q3 | $46M | Buy |
1,202,763
+285,060
| +31% | +$11M | 0.03% | 486 |
|
|
2020
Q2 | $32.2M | Buy |
917,703
+317,942
| +53% | +$11.4M | 0.03% | 571 |
|
|
2020
Q1 | $19.6M | Sell |
599,761
-59,111
| -9% | -$2.31M | 0.02% | 750 |
|
|
2019
Q4 | $29.8M | Sell |
658,872
-224,370
| -25% | -$9.39M | 0.02% | 752 |
|
|
2019
Q3 | $35.9M | Sell |
883,242
-675,045
| -43% | -$28.6M | 0.03% | 603 |
|
|
2019
Q2 | $67M | Buy |
1,558,287
+871,015
| +127% | +$33.5M | 0.05% | 341 |
|
|
2019
Q1 | $26.4M | Buy |
687,272
+106,233
| +18% | +$4.06M | 0.03% | 690 |
|
|
2018
Q4 | $20.5M | Buy |
581,039
+338,441
| +140% | +$12.3M | 0.02% | 816 |
|
|
2018
Q3 | $9.34M | Sell |
242,598
-16,851
| -6% | -$589K | 0.01% | 1336 |
|
|
2018
Q2 | $8.48M | Sell |
259,449
-196,490
| -43% | -$5.93M | 0.01% | 1417 |
|
|
2018
Q1 | $12.5M | Buy |
455,939
+86,149
| +23% | +$2.34M | 0.01% | 1091 |
|
|
2017
Q4 | $9.17M | Sell |
369,790
-11,621
| -3% | -$321K | 0.01% | 1356 |
|
|
2017
Q3 | $11.1M | Buy |
381,411
+231,993
| +155% | +$6.41M | 0.01% | 1162 |
|
|
2017
Q2 | $4.14M | Buy |
149,418
+60,217
| +68% | +$1.6M | ﹤0.01% | 1864 |
|
|
2017
Q1 | $2.22M | Buy |
89,201
+4,435
| +5% | +$108K | ﹤0.01% | 2376 |
|
|
2016
Q4 | $1.83M | Sell |
84,766
-21,939
| -21% | -$479K | ﹤0.01% | 3056 |
|
|
2016
Q3 | $2.54M | Sell |
106,705
-2,071
| -2% | -$49.4K | ﹤0.01% | 2285 |
|
|
2016
Q2 | $2.54M | Sell |
108,776
-152,642
| -58% | -$3.3M | ﹤0.01% | 2160 |
|
|
2016
Q1 | $4.92M | Buy |
261,418
+153,652
| +143% | +$2.7M | 0.01% | 1572 |
|
|
2015
Q4 | $1.99M | Buy |
107,766
+6,233
| +6% | +$112K | ﹤0.01% | 2490 |
|
|
2015
Q3 | $1.67M | Sell |
101,533
-127,759
| -56% | -$2.18M | ﹤0.01% | 2623 |
|
|
2015
Q2 | $4.06M | Buy |
229,292
+118,092
| +106% | +$2.11M | ﹤0.01% | 1917 |
|
|
2015
Q1 | $1.98M | Sell |
111,200
-189,477
| -63% | -$2.99M | ﹤0.01% | 2490 |
|
|
2014
Q4 | $3.98M | Sell |
300,677
-182,960
| -38% | -$2.34M | ﹤0.01% | 1963 |
|
|
2014
Q3 | $5.71M | Sell |
483,637
-191,103
| -28% | -$2.41M | 0.01% | 1724 |
|
|
2014
Q2 | $8.62M | Buy |
674,740
+30,116
| +5% | +$392K | 0.01% | 1364 |
|
|
2014
Q1 | $8.71M | Sell |
644,624
-1,163,786
| -64% | -$15.3M | 0.01% | 1259 |
|
|
2013
Q4 | $21.7M | Buy |
1,808,410
+1,132,057
| +167% | +$13.4M | 0.02% | 724 |
|
|
2013
Q3 | $7.94M | Sell |
676,353
-130,464
| -16% | -$1.41M | 0.01% | 1374 |
|
|
2013
Q2 | $7.48M | Buy |
+806,817
| New | +$6.84M | 0.01% | 1303 |
|
Other funds holding BSX
VCM
VPM
Citigroup's BSX Position: Q2 2026 in Review
Citigroup increased its Boston Scientific (BSX) stake by 64% in Q2 2026, buying an estimated $54.6M and bringing the position to 2,582,561 shares worth $110M. The position accounts for 0.04% of the portfolio, ranked #441.
Citigroup first reported a position in BSX in Q2 2013 and has held it in 53 quarters since. The position peaked at $433M in Q2 2025. 1,186 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- Citigroup held 2,582,561 shares of Boston Scientific worth $110M as of Q2 2026.
- Citigroup bought 1,005,921 Boston Scientific shares in Q2 2026, an estimated $54.6M.
- Boston Scientific made up 0.04% of Citigroup's portfolio in Q2 2026, its #441 holding.
- Citigroup first reported a position in Boston Scientific in Q2 2013 and has held it in 53 quarters since.
- Citigroup's Boston Scientific position peaked at $433M in Q2 2025.
- 1,186 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.